Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.870 USD | +1.77% |
|
-1.71% | +4.36% |
| Market Cap | 32Cr 28Cr 26Cr 24Cr 45Cr 3.07TCr 46Cr 311.81Cr 122.05Cr 1.52TCr 120.74Cr 118.13Cr 5.26TCr | P/E 2026 * |
-2.56x | P/E 2027 * | -2.49x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 130.39Cr 51Cr 637.21Cr 50Cr 49Cr 2.2TCr | EV / Sales 2026 * |
318x | EV / Sales 2027 * | 19.1x |
| Free-Float |
89.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | +1.77% | ||
| 1 week | -3.69% | ||
| Current month | -15.84% | ||
| 1 month | -19.15% | ||
| 3 months | -27.34% | ||
| 6 months | +12.11% | ||
| Current year | +4.36% |
| 1 week | 2.69 |  | 3.03 |
| 1 month | 2.69 | | 3.78 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 05/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 04/09/2025 |
Paul Lyne
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 05/02/2023 |
Lori Woods
CHM | Chairman | 63 | 03/02/2023 |
| Director/Board Member | 60 | 05/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/03/26 | Free | Director | 50,000 | 0.0439% | ||
| 02/03/26 | Free | Director | 50,000 | 0.0439% | ||
| 02/03/26 | Free | Controller/Auditor | 90,000 | 0.0790% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | -3.69% | -30.34% | -51.36% | 32Cr | |
| +0.14% | -0.85% | -1.20% | +11.73% | 4.77TCr | |
| -2.24% | +0.31% | +393.45% | +615.13% | 4TCr | |
| +1.40% | +3.69% | +12.21% | +46.79% | 3.62TCr | |
| +13.94% | +20.49% | +22.85% | +7.42% | 3.56TCr | |
| -0.73% | +2.78% | +4.65% | +41.16% | 2.79TCr | |
| +0.40% | -0.30% | - | - | 1.67TCr | |
| -3.12% | +7.39% | +26.03% | +124.08% | 1.65TCr | |
| +2.39% | -3.63% | -0.35% | +10.34% | 1.32TCr | |
| +6.79% | +8.17% | -4.97% | -28.52% | 1.29TCr | |
| Average | +2.14% | +2.16% | +46.92% | +86.31% | 2.47TCr | |
| Weighted average by Cap. | +2.22% | +2.95% | +75.57% | +130.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4L 4L 3L 3L 6L 4.04Cr 6L 41.03L 16.06L 2Cr 15.89L 15.54L 6.93Cr | 5L 4L 4L 4L 7L 4.66Cr 7L 47.27L 18.5L 2.31Cr 18.3L 17.91L 7.98Cr |
| Net income | -12Cr -11Cr -9.82Cr -9.03Cr -17Cr -1.15TCr -17Cr -116.46Cr -46Cr -569.13Cr -45Cr -44Cr -1.97TCr | -14Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -20Cr -133.94Cr -52Cr -654.54Cr -52Cr -51Cr -2.26TCr |
| Net Debt | -19Cr -16Cr -15Cr -14Cr -26Cr -1.79TCr -27Cr -181.42Cr -71Cr -886.57Cr -70Cr -69Cr -3.06TCr | -31Cr -27Cr -26Cr -23Cr -44Cr -2.98TCr -45Cr -302.79Cr -118.52Cr -1.48TCr -117.25Cr -114.71Cr -5.11TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $2.870 | +1.77% | 9,99,528 |
| 27/26/27 | $2.820 | -3.09% | 8,12,765 |
| 24/26/24 | $2.910 | -1.36% | 6,71,334 |
| 23/26/23 | $2.950 | -0.67% | 5,82,707 |
| 22/26/22 | $2.970 | -0.34% | 11,51,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
